Thats interesting HERO, but in the event of increased sales (distribution growth is excellent), more stock is required - put late payers in the mix, commitments for marketing spend and you have a classic recipe for limited ability to grow. I was not suggesting cash in bank for interest purposes - thats slightly naive with a company at this careful stage of its growth. Good luck.
There isn't a huge amount of cash given this company is high growth and is now relying on larger and larger marketing spends. Does anybody think a raise is required in the short term to facilitate growth or is the fact there has been recent director buys a sign no cash injection/dilution is required?
The Group currently intends to release its Final Results for the financial year ending 31 July 2019 on 31 October 2019, but this date is subject to change in light of any requirements arising from the FSP described above.
It will reverse back RF as I'm sure you well know. Fundamentals are very good, momentum plays are the in thing, and this hasn't got that currently. I could well be wrong in my view, but still see upper 40's as the reversal point. Thanks.
I do not just post anything. There is a seller here and the reason being IMO - the company has yet to steady the revenue decline. Admittedly its lining lower bolli, but ultimately the trend is down. Lack of volume is not helpful either. Just one of those stocks that has a month or so of decline, again, IMO.